Awards celebrate WA s most accessible communities miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus
Dr. Eric Morand Publishes Results Funded by LRA s Distinguished Innovator Award
News provided by
Share this article
Share this article
NEW YORK, April 1, 2021 /PRNewswire/ Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with steroids effective at lower doses, lessening harmful side effects.
In a study just published in
Lancet Rheumatology, Dr. Morand (with first author rheumatology fellow. Dr. Melissa Northcott) reports identifying a group of biological markers that can indicate how much steroid lupus patients have been exposed to, since the amount that is active in the body is more important than the amount taken. The paper further shows that high activity of proteins made by the immune system, called interferons, can block the effects of steroid treatmen